Crossmark

Efficacy and safety of erenumab in migraine prevention: evidences from direct and indirect comparisons

Published Online: 2021-11-03

Published Print: 2022-04

Authors

Wang, Xing

He, Qiang

Wen, Dingke

Ma, Lu

You, Chao https://orcid.org/0000-0003-4364-4060
Funding

Funding for this research was provided by:

Key Technologies Research and Development Program (2018YFA0108604, 2018YFA0108603)

the 1·3·5 project for disciplines of excellence–Clinical Research Incubation Project, West China Hospital, Sichuan University (2018HXFH008, 2018HXFH010)
License Information

Text and Data Mining valid from 2021-11-03

Version of Record valid from 2021-11-03
More Information

Article History

Received: 15 October 2021

Accepted: 26 October 2021

First Online: 3 November 2021

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current